Tsoukas MA. Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use. Can Diabetes Endocrinol Today [Internet]. 2023 Oct. 12 [cited 2024 Dec. 22];1(3):21–26. Available from: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/1-3-tsoukas